Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2025-09-29
12 Health Care Stocks Moving In Monday's After-Market SessionNBY — NovaBay Pharmaceuticals Inc
AMEX · Pharmaceuticals · Pharmaceuticals
$1.95-57.14%Market cap37.81M
- Latest Close
- $1.95
- 30-Day Move
- -57.1%
- Market Cap
- $38M
- Shares Outstanding
- 26,120,000
- P/B Ratio
- 0.4
- ROE
- -290.9%
AMEX:NBYPharmaceuticals / PharmaceuticalsDelayed public snapshot
NovaBay Pharmaceuticals Inc
A read-only Alphactor snapshot forNovaBay Pharmaceuticals Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-02
Topline snapshot
Latest Close
$1.95
30-Day Move
-57.1%
Market Cap
$38M
Shares Outstanding
26,120,000
P/B Ratio
0.4
ROE
-290.9%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$1.95
-57.1%last 90 delayed daily bars
Market cap$38M
90D High
$99.75
90D Low
$1.11
Avg Volume
492,941
What stands out
Gross margin is running at 66.3%, which gives a quick read on operating quality before you open the full model.
Net margin is -73.8%, useful for comparing NBY against peers in Pharmaceuticals.
NBY is down 57.1% over the last 30 trading days shown on this page.
Latest operating income is $-8M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Rule of 40
-68.4%
Dark Pool Short %
11.3%
Fundamentals snapshot
Latest Close
$1.95
30-Day Move
-57.1%
Market Cap
$38M
Shares Outstanding
26,120,000
P/B Ratio
0.4
ROE
-290.9%
ROA
-211.0%
Gross Margin
66.3%
Operating Margin
-59.8%
Net Margin
-73.8%
Debt / Equity
0.34
Current Ratio
0.68
Dividend Yield
0.0%
Latest Revenue
$0
Financial statement snapshot
Revenue
$0
Gross Profit
--
Operating Income
$-8M
Net Income
$-22M
Gross Margin
6626.0%
Net Margin
-7385.0%
Current Ratio
0.68
Debt / Equity
0.34
Quality snapshot
Altman Z
-33.67
Distress
Piotroski
3
Weak (0-3)
Cash Conversion
0.38x
Rule of 40
-68.4%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $14M | $-8M | $-11M | $-7M |
| 2023-12-31 | $10M | $-4M | $-10M | $-4M |
| 2024-12-31 | $0 | $-7M | $-7M | $-7M |
| 2025-12-31 | $0 | $-8M | $-22M | $-8M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2025-09-18
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual MeetingPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2024-09-02
Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/investing.ico', homepage_url='https://www.investing.com/', logo_url='https://s3.massive.com/public/assets/news/logos/investing.png', name='Investing.com')•2024-07-16
NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.comPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/investing.ico', homepage_url='https://www.investing.com/', logo_url='https://s3.massive.com/public/assets/news/logos/investing.png', name='Investing.com')•2024-07-11
NovaBay reports 9% increase in eyecare revenue in 2024 - Investing.comAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$0
Buys
3
Sells
1
Buy Value
$0
Sell Value
$0
Buy/Sell Ratio
3.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | Freiman Paul E. | A | 140,000 | $0.00 |
| 2026-03-31 | Zheng Yenyou | A | 140,000 | $0.00 |
| 2026-03-31 | Law Tommy | A | 300,000 | $0.00 |
| 2026-03-31 | Kazley Michael John | A | 7,722,802 | $0.00 |
| 2026-03-31 | Kazley Michael John | A | 4,118,828 | $0.00 |
| 2026-03-31 | Sit Swan | A | 140,000 | $0.00 |
| 2025-10-21 | Lazar David E. | M | 39,925 | $0.00 |
| 2025-10-21 | Lazar David E. | A | 6,388,000 | $0.00 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 227,432 | 0.01% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 130,744 | 0.00% | 2026-02-28 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 55,315 | 0.00% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 47,860 | 0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 38,159 | 0.00% | 2026-02-28 |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 18,652 | 0.00% | 2026-01-31 |
| Victory PORT.s III-Victory Extended Market Index Fd. (Formerly USAA Ex | 2,855 | 0.00% | 2026-01-31 |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 6 | 0.00% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Vanguard Group
Filed 2026-01-29
$10M
+2065.1%
Geode Capital Management
Filed 2026-02-09
$7M
+2331.7%
Northern Trust
Filed 2026-02-17
$2M
--
Goldman Sachs
Filed 2026-02-10
$588,483
--
Charles Schwab
Filed 2026-02-13
$525,992
--
Qube Research & Technologies
Filed 2026-02-17
$230,259
--
Bank of New York Mellon
Filed 2026-02-10
$145,507
--
Dark-pool activity snapshot
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.